Compare DLTR & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DLTR | DXCM |
|---|---|---|
| Founded | 1986 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 25.9B |
| IPO Year | 1996 | 2005 |
| Metric | DLTR | DXCM |
|---|---|---|
| Price | $129.44 | $73.77 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 18 | 21 |
| Target Price | ★ $122.88 | $85.00 |
| AVG Volume (30 Days) | 2.7M | ★ 4.7M |
| Earning Date | 03-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 47.18 |
| EPS | ★ 3.72 | 2.09 |
| Revenue | ★ $17,578,500,000.00 | N/A |
| Revenue This Year | $12.95 | $14.46 |
| Revenue Next Year | $6.27 | $12.39 |
| P/E Ratio | ★ $34.33 | $35.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $61.80 | $54.11 |
| 52 Week High | $142.40 | $89.07 |
| Indicator | DLTR | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 50.62 | 60.54 |
| Support Level | $113.11 | $63.69 |
| Resistance Level | $132.48 | $75.67 |
| Average True Range (ATR) | 4.29 | 2.43 |
| MACD | 0.34 | 0.29 |
| Stochastic Oscillator | 42.64 | 93.85 |
Founded in 1986, Dollar Tree operates almost 9,000 small-box discount stores across the United States and Canada, offering roughly 85% of its merchandise under $2. The chain targets value-conscious suburban and urban shoppers with a mix of consumables (49% of sales), variety (45%), and seasonal goods (6%). In fiscal 2024, Dollar Tree generated over $17 billion in sales, through its multi-price strategy, higher-margin discretionary assortments, and private-label products that account for nearly one-third of sales.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.